Smokeless tobacco (ST) use is a leading, yet preventable, cause of oral cancer and related mortality worldwide. Although the health risks of ST are well established, its use continues to rise in many regions, particularly in low- and middle-income countries (LMICs). Addressing this growing public health challenge requires not only effective policy but also strong […]
Tag Archives: Healthcare Challenges
For much of the past decade, telehealth advocates have focused on payment parity—the principle that virtual visits should be reimbursed at the same rate as in-person care. During the COVID-19 public health emergency, payment parity played a critical role in rapidly expanding access to care, stabilizing physician practices, and normalizing virtual medicine. But as telehealth […]
On November 6, 2025, the Trump administration announced new pricing and coverage agreements with Eli Lilly and Novo Nordisk for widely used glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (Mounjaro®, Zepbound®) and semaglutide (Ozempic®, Wegovy®). These agreements aim to lower out-of-pocket costs for some patients and expand access under federal health programs beginning in 2026. […]
Rural communities across the United States continue to face deep, long-standing healthcare challenges: long travel distances to clinics, shortages of specialists, hospital closures, and limited access to timely, high-quality care. These barriers contribute to higher rates of chronic disease, later diagnoses, and poorer health outcomes for millions of rural residents. A recent perspective in the […]




